BioCentury
ARTICLE | Company News

BioQuest, Immune Complex deal

June 15, 1998 7:00 AM UTC

HIVX signed agreements with original shareholders of Immune Complex, an HIVX subsidiary, to reduce to 20 percent from a majority shareholder position HIVX’s holdings in Immune Complex. HIVX will receive an undisclosed amount of cash and promissory notes, and will not be responsible for funding future Immune Complex activities. ...